|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 178.85 ZAR | +0.88% |
|
-1.99% | -1.52% |
| 11:46am | Remgro sells about 52 million additional FirstRand shares | RE |
| 16/01 | Remgro says negotiations on potential Mediclinic restructuring ongoing | RE |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 6.58TCr | 7.61TCr | 4.82TCr | 5.04TCr | 5.15TCr | |||||
Total Revenues | 6.58TCr | 7.61TCr | 4.82TCr | 5.04TCr | 5.15TCr | |||||
Cost of Goods Sold, Total | 4.01TCr | 4.78TCr | 3.08TCr | 3.22TCr | 3.26TCr | |||||
Gross Profit | 2.57TCr | 2.83TCr | 1.73TCr | 1.82TCr | 1.89TCr | |||||
Selling General & Admin Expenses, Total | 1.09TCr | 1.19TCr | 776.4Cr | 834.8Cr | 922.5Cr | |||||
Depreciation & Amortization - (IS) | 171.1Cr | 189.2Cr | 103.2Cr | 112.6Cr | 129.2Cr | |||||
Other Operating Expenses | 886Cr | 941.2Cr | 622.7Cr | 608.4Cr | 529Cr | |||||
Other Operating Expenses, Total | 2.15TCr | 2.32TCr | 1.5TCr | 1.56TCr | 1.58TCr | |||||
Operating Income | 424.4Cr | 510.5Cr | 231.6Cr | 268Cr | 308.7Cr | |||||
Interest Expense, Total | -154.8Cr | -122.9Cr | -100.2Cr | -93Cr | -50Cr | |||||
Interest And Investment Income | 81Cr | 117.8Cr | 214.6Cr | 164.6Cr | 149.2Cr | |||||
Net Interest Expenses | -74Cr | -5.1Cr | 114.4Cr | 71Cr | 99Cr | |||||
Income (Loss) On Equity Invest. | 161.8Cr | 1.1TCr | 329.6Cr | 279.9Cr | 161.7Cr | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 512.6Cr | 1.6TCr | 675.6Cr | 619.2Cr | 569.3Cr | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 114.9Cr | 56Cr | 28Cr | -388Cr | -72Cr | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | -9.3Cr | -1.5Cr | -50Cr | -8.2Cr | -83Cr | |||||
Other Unusual Items | 80L | - | - | - | - | |||||
EBT, Incl. Unusual Items | 619Cr | 1.66TCr | 653.5Cr | 223Cr | 414.3Cr | |||||
Income Tax Expense | 113.5Cr | 160.2Cr | 83Cr | 95Cr | 96Cr | |||||
Earnings From Continuing Operations | 505.5Cr | 1.5TCr | 570.3Cr | 128.2Cr | 318.6Cr | |||||
Earnings Of Discontinued Operations | - | - | 378.8Cr | 43Cr | - | |||||
Net Income to Company | 505.5Cr | 1.5TCr | 949.1Cr | 170.9Cr | 318.6Cr | |||||
Minority Interest | -150.5Cr | -184Cr | 13Cr | -47Cr | 12Cr | |||||
Net Income - (IS) | 355Cr | 1.31TCr | 962.4Cr | 124.1Cr | 330.3Cr | |||||
Net Income to Common Incl Extra Items | 355Cr | 1.31TCr | 962.4Cr | 124.1Cr | 330.3Cr | |||||
Net Income to Common Excl. Extra Items | 355Cr | 1.31TCr | 583.6Cr | 81Cr | 330.3Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.28 | 23.28 | 17.1 | 2.24 | 5.95 | |||||
Basic EPS - Continuing Operations | 6.28 | 23.28 | 10.37 | 1.47 | 5.95 | |||||
Basic Weighted Average Shares Outstanding | 56Cr | 56Cr | 56Cr | 55Cr | 56Cr | |||||
Net EPS - Diluted | 6.25 | 23.13 | 16.96 | 2.18 | 5.86 | |||||
Diluted EPS - Continuing Operations | 6.25 | 23.13 | 10.27 | 1.41 | 5.86 | |||||
Diluted Weighted Average Shares Outstanding | 57Cr | 57Cr | 57Cr | 56Cr | 56Cr | |||||
Normalized Basic EPS | 3.01 | 14.5 | 7.74 | 6.13 | 6.62 | |||||
Normalized Diluted EPS | 3 | 14.42 | 7.7 | 6.1 | 6.58 | |||||
Dividend Per Share | 0.9 | 1.5 | 2.4 | 2.64 | 3.44 | |||||
Payout Ratio | 14.25 | 5.49 | 11.17 | 131.91 | 57.01 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 636.3Cr | 737.8Cr | 450.4Cr | 366.4Cr | 419.1Cr | |||||
EBITA | 465.2Cr | 548.6Cr | 265.3Cr | 270.1Cr | 312.7Cr | |||||
EBIT | 424.4Cr | 510.5Cr | 231.6Cr | 268Cr | 308.7Cr | |||||
EBITDAR | 701.2Cr | 799.4Cr | 478.2Cr | 395.6Cr | 454.9Cr | |||||
Effective Tax Rate - (Ratio) | 18.34 | 9.66 | 12.73 | 42.51 | 23.1 | |||||
Total Current Taxes | 110Cr | 177Cr | 207.5Cr | 104.4Cr | 80Cr | |||||
Total Deferred Taxes | 3.5Cr | -17Cr | -7.2Cr | 7.6Cr | 15Cr | |||||
Normalized Net Income | 169.88Cr | 818.12Cr | 435.55Cr | 340.2Cr | 367.51Cr | |||||
Interest on Long-Term Debt | - | - | - | 6.1Cr | 8.4Cr | |||||
Non-Cash Pension Expense | -1.8Cr | -2.8Cr | -3.4Cr | -3.7Cr | -3.8Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 165Cr | 185.3Cr | 86Cr | 77Cr | 83Cr | |||||
Selling and Marketing Expenses | 165Cr | 185.3Cr | 86Cr | 77Cr | 83Cr | |||||
Research And Development Expense From Footnotes | 3.7Cr | 3.2Cr | 1.8Cr | 1.4Cr | 1.4Cr | |||||
Net Rental Expense, Total | 65Cr | 62Cr | 28Cr | 29Cr | 36Cr | |||||
Imputed Operating Lease Interest Expense | 36Cr | 37Cr | 16Cr | 22Cr | 25Cr | |||||
Imputed Operating Lease Depreciation | 29Cr | 25Cr | 12Cr | 6.93Cr | 11Cr | |||||
Maintenance & Repair Expenses, Total | 149.5Cr | 175Cr | 142Cr | 156.2Cr | 164.8Cr | |||||
Stock-Based Comp., SG&A Exp. (Total) | 32Cr | 25Cr | 17Cr | 17Cr | 17Cr | |||||
Stock-Based Comp., Other (Total) | - | - | -89Cr | - | - | |||||
Total Stock-Based Compensation | 32Cr | 25Cr | -72Cr | 17Cr | 17Cr |
- Stock Market
- Equities
- REM Stock
- Financials Remgro Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















